IGF-1 DES
IGF-1 DES
Also known as: DES IGF-1, IGF-1 DES(1-3), Truncated IGF-1
Overview
Key Facts
Primary Goal: Research and therapeutic applications of IGF-1 DES
Binds IGF-1R with high affinity but minimal IGFBP interaction, resulting in maximal receptor activation. Potent PI3K/Akt/mTOR activation for protein synthesis at the injection site.
Dosing Information
makes it ideal for targeted, site-specific intramuscular injections to promote localized muscle growth.Half-Life20-30 minutes
20–80 mcg
Pre-workout or immediately post-workout, bilaterally into target muscle
4-6 weeks on, 2-4 weeks off
Benefits
- Highly potent localised anabolic effect at injection site
- Promotes satellite cell activation and muscle hyperplasia
- Short half-life limits systemic exposure and organ growth risk
- Rapid onset of action at the injection site
- Synergistic with exercise-induced IGF-1 expression
Side Effects
Mechanism of Action
Binds IGF-1R with high affinity but minimal IGFBP interaction, resulting in maximal receptor activation
Potent PI3K/Akt/mTOR activation for protein synthesis at the injection site
Stimulates local satellite cell proliferation and myoblast differentiation
Short half-life confines most biological activity to the local tissue environment
Contraindications
Do not use this peptide if any of the following apply:
- Active or history of malignancy
- Diabetes or insulin-dependent conditions
- Pregnancy or breastfeeding
- Under 25 years of age
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Des(1-3) IGF-1 was originally identified as a naturally occurring brain IGF-1 variant. In vitro studies demonstrate 5-10x greater mitogenic potency than full-length IGF-1 in myoblast cultures. Animal studies confirm enhanced muscle protein synthesis with local administration. Research in dairy cattle showed significant mammary growth effects. It remains a research compound with no clinical trials in humans for muscle indications.
Frequently Asked Questions
Common questions about IGF-1 DES
UK-Specific Information
Exclusive data points and guidance for UK residents using IGF-1 DES
UK Lab Testing
UK Lab Testing
Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.
Share on TikTok
Generate a trackable link to share this peptide information on TikTok